Collaborating for What’s Now & What’s Next: Insilico

01/21/2021
JPM_Insilico_V3

Collaborating for What’s Now & What’s Next: Insilico

Insilico Medicine “graduated” as a resident of Johnson & Johnson Innovation – JLABS with a Janssen collaboration for multi-target AI-powered drug discovery.

Related video

Related videos

Collaborating for What’s Now & What’s Next: 1859

Related article

Related articles

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Full article

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Full article